Global Coronary Artery Bypass Graft Market By Product Type (Saphenous Vein Grafts, Internal Thoracic Artery Grafts, and Other Grafts), By Surgery Procedure (Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, and Others), By Technology (On-Pump CABG and Off-Pump CABG), By Technique (Conventional Vessel Harvesting and Endoscopic Vessel Harvesting), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Coronary Artery Bypass Graft Market Overview:

The global market for coronary artery bypass grafts was estimated to be worth USD 87 million in 2021. This market is estimated to grow at a rate of 6.10% over the forecast period.

Increased prevalence of disorders such as hypertension, Coronary Heart Disease, Coronary Artery Disease, Myocardial Infarction, Myocardial Infarction, and peripheral artery disease. In addition, technologically advanced devices are also likely to boost this market expansion.

CVDs, which can be caused due to poor lifestyle choices, stress, or eating fast food are some of the primary causes of death in the world. According to WHO, cardiovascular diseases are the most common cause of death.

Globally, 31.0 % of fatalities were due to cardiovascular disease (CVD). They were responsible for approximately 17.5 Mn deaths in 2012. Around 6.4 Mn to stroke and 7.4 Mn of these 17.5 Mn deaths could be attributed to heart disease. It is expected that by 2032, the death toll will be around 23.6 Mn.

Global Coronary Artery Bypass Graft Market Analysis

Graft Type Analysis

The market analysis focuses on the saphenous vein and internal thoracic artery graft segments. The saphenous vein graft segment registered the highest market share in 2021. It is projected to grow at a profitable rate in the future. The demand for Saphenous Vein Grafts (SVG), which are more flexible, easier to handle, and require less transfusion, has increased in the market for coronary bypass grafts.

The radial and gastroepiploic arteries are then separated from the rest of the graft. The Right Gastroepiploic Artery is a conduit for coronary bypass surgery that is an alternative to the left coronary artery. It’s utilized to harvest grafts from patients who don’t have enough saphenous veins.

Surgical Procedure Analysis

Due to the rising prevalence of CVDs like CAD, CHD, or strokes worldwide, the triple CABG surgery segment will dominate this industry. The procedure of a double bypass is very widespread globally. This will be the highest and most profitable market, with a high CAGR expected over the projected period.

Technology Analysis

The on-pump market was the largest segment in 2021. The market has developed significantly as a result of the increased use of oxygenators, machines for heart-lung, stabilizers, positioners, and cardiac and cardiothoracic surgeons’ predilection for on-pump CABG surgeries.

The off-pump segment will increase its market share over the projection period. With the development of innovative techniques like (TECAB) and Totally Endoscopic Coronary Artery Bypass, this vertical is likely to grow.

Technique Analysis

The conventional vessel harvesting segment will dominate the market owing to its use in graft surgeries of the coronary bypass which has increased. The introduction of endoscopic vessel harvesting techniques is projected to lower this segment’s market share. They are less prone than standard longitudinal incisions to cause scarring, infection, or morbidity, which can lead to better outcomes.

Over the projection period, EVH’s market share is likely to grow. This portion eliminates the requirement for extensive incisions, which are necessary with traditional open harvesting. It reduces postoperative discomfort, lowers the incidence of infection of wounds, and improves patient satisfaction.

Key Market Segments

By Graft Type

• Internal Thoracic Artery Grafts
• Saphenous Vein Grafts
• Other Grafts
• Radial Artery
• Gastroepiploic Artery

By Surgical Procedure

• Quadruple CABG Surgery
• Triple CABG Surgery
• Double CABG Surgery
• Single CABG Surgery

By Technology

• Off-Pump CABG
• On-Pump CABG

By Technique

• Endoscopic Vessel Harvesting
• Conventional Vessel Harvesting

Market Dynamics

Globally, the geriatric population is expected to drive the increase in coronary artery bypass surgery. This will bolster the growth of the vertical over the forecast period. The American Heart Association (AHA), estimates that the global geriatric population will account for around 20.0% of the world’s total population by 2032.

According to the AHA statistics, 5,19,000 CAB-G procedures were performed in the United States in 2012. Of these, 371,000 were men and 148,000 on females. According to estimates, more than 800,000. CABG surgeries are performed each year worldwide.

Over the forecast period, the demand for CABG surgery is expected to rise due to the introduction of new technologies such as Minimally Invasive Direct Coronary Artery Bypass or keyhole, Anasist Devices(AAD), and Endoscopic Vessel Harvesting. MIDCAB, a less invasive CABG procedure, allows for easier access to the heart via a smaller incision.

MIDCAB uses off-pump technology and is performed without the use of a heart-lung machine. MIDCAB has many benefits, including faster recovery, less bleeding & blood trauma and lower infection rates, as well as a low cost of surgery.

Regional Analysis

North America accounted for 56.9% of the coronary artery bypass graft market share in 2021. This is due to increasing CVD prevalence, the presence, and changing lifestyles of people in Canada and the US.

APAC had a significant market share in 2021. This was because of the increasing number of coronary artery bypass graft procedures in Japan and India. Moreover, due to growing patient awareness and growing population about these diseases this market is growing in this region. Europe is likely to see a high CAGR relative to the past owing to the high figure of CABG operations performed in Europe.

Key Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis:

The key players in this market include Medtronic plc, Terumo Corporation, Guidant Corporation, Maquet, Vitalitec International GmbH, Novadaq Inc., KARL STORZ SE & Co. KG, and Edwards Lifesciences. These companies are focused on growth approaches or strategies like acquisition and merger, product launch as well as regional expansion.

Маrkеt Кеу Рlауеrѕ:

• Medtronic plc
• Terumo Corporation
• Guidant Corporation
• Maquet Vitalitec
• International GmbH
• Novadaq Technologies Inc.
• KARL STORZ SE & Co. KG
• Edwards Lifesciences
• Other Key Players

For the Coronary Artery Bypass Graft Market research study, the following years have been considered to estimate the market size: